Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Common Stockholders

The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders (in thousands, except share and per share data):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Basic EPS
Numerator:
Net income	$	434,420	$	108,639	$	980,572	$	184,478
Less:
Income attributable to options exercised by promissory notes	(110)		(442)		(1,169)		(720)
Income attributable to common stock subject to share repurchase agreements	—		(360)		(1,001)		(228)
Income attributable to unvested early exercised options	—		(2)		(2)		(15)
Net income attributable to common stockholders—Basic	$	434,310	$	107,835	$	978,400	$	183,515
Denominator:
Weighted-average shares used in computing net income per share—Basic	336,931,269		341,435,759		336,167,052		357,009,609
Net income per share attributable to common stockholders—Basic:	$	1.29	$	0.32	$	2.91	$	0.51
Diluted EPS
Numerator:
Net income	$	434,420	$	108,639	$	980,572	$	184,478
Less:
Income attributable to options exercised by promissory notes	(106)		(423)		(1,129)		(698)
Income attributable to common stock subject to share repurchase agreements	—		(345)		(967)		(220)
Income attributable to unvested early exercised options	—		(2)		(2)		(15)
Net income attributable to common stockholders—Diluted	$	434,314	$	107,869	$	978,475	$	183,545
Denominator:
Weighted-average shares used in computing net income per share—Basic	336,931,269		341,435,759		336,167,052		357,009,609
Weighted-average dilutive stock awards	11,294,194		15,470,463		12,105,565		11,249,904
Weighted-average shares used in computing net income per share—Diluted	348,225,463		356,906,222		348,272,617		368,259,513
Net income per share attributable to common stockholders—Diluted:	$	1.25	$	0.30	$	2.81	$	0.50

Schedule of Antidilutive Potential Common Shares

The following table presents the forms of antidilutive potential common shares:

	As of September 30,
	2024	2023
Stock options exercised for promissory notes	85,000	1,399,999
Early exercised stock options	—	5,736
Stock options	—	613,968
Unvested RSUs	—	4,747,127
ESPP	32,784	—
Total antidilutive potential common shares	117,784	6,766,830